The effect of valerian on cognitive disorders in hemodialysis' patients
Not Applicable
- Conditions
- Hemodialysis patients.Dementia in other specified diseases classified elsewhere
- Registration Number
- IRCT201606076318N7
- Lead Sponsor
- Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Over 18 years of age; hemodialysis 3 times a week for 3 hours; for more than 3 months; full consciousness; hearing and speech ability; and not having sensitivity to plants. Exclusion criteria: Physical or mental disability; drug abuse; cancer; hearing or visual disorder; experienced recent stressful event; kidney transplant; acute illness; body mass index over 30; liver disease; hepatitis; cirrhosis; travel; or death of the patient.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive status. Timepoint: Before the intervention, one month after the first intervention, one month after the cleansing and one month after the second intervention. Method of measurement: In this study, Cognitive status is measured by using Electroencephalography (EEG) and MMSE questionnaire. This measurement is performed within three consecutive months (before the intervention, one month after the first intervention, one month after the cleansing and one month after the second intervention). The score for total cognitive health is (25-30), for mild cognitive disorder is (21-24), for moderate disorder is (10-20) and for severe disorder is (<9). Information for each person will be recorded in their personal questionnaire.
- Secondary Outcome Measures
Name Time Method